Management of Chronic Total Occlusion of Coronary Artery

Abstract

Chronic total occlusion (CTO) of a coronary artery is typically defined as a completely occluded artery without any antegrade flow and a duration of at least 3 months. We reviewed the current literature describing the optimal management of CTO including the role of revascularization and choice of modality, i.e., percutaneous coronary intervention (PCI) or coronary artery bypass graft surgery. Databases (PubMed, the Cochrane Library, Embase, EBSCO, Web of Science, and CINAHL) were searched and relevant studies of patients with CTO were selected for review. The prevalence of coronary artery CTOs is approximately 25% among patients undergoing coronary angiography for angina. Available data suggests that PCI of CTO can be a technically complex procedure with relatively lower success rates compared with non-CTO PCI and typically associated with a higher complication rate especially at nonspecialized centers. Furthermore, successful CTO-PCI is associated with symptomatic improvement but does not appear to improve mortality, myocardial infarction, stroke, and repeat revascularization rates. Based on contemporary data, PCI of CTO lesions may be considered in patients with incapacitating angina despite treatment with optimal guideline-directed medical therapy and in whom based on coronary anatomy there is a reasonable chance of technical success with an acceptable risk.

Keywords

chronic total occlusion - percutaneous coronary intervention - complete revascularization - optimal medical therapy - revascularization

Publikationsverlauf

Artikel online veröffentlicht:
03. Dezember 2020

• References

• 1 Agrawal H, Lange RA, Montanez R. et al. The role of percutaneous coronary intervention in the treatment of chronic total occlusions: rationale and review of the literature. Curr Vasc Pharmacol 2019; 17 (03) 278-290
• 2 Fefer P, Knudtson ML, Cheema AN. et al. Current perspectives on coronary chronic total occlusions: the Canadian Multicenter Chronic Total Occlusions Registry. J Am Coll Cardiol 2012; 59 (11) 991-997
• 3 Tsai TT, Stanislawski MA, Shunk KA. et al. Contemporary incidence, management, and long-term outcomes of percutaneous coronary interventions for chronic coronary artery total occlusions: insights from the VA CART program. JACC Cardiovasc Interv 2017; 10 (09) 866-875
• 4 Mukherjee D, Roffi M. Chronic total occlusions in non-infarct-related arteries. Eur Heart J 2012; 33 (06) 695-697
• 5 Ursoniu S, Mikhailidis DP, Serban MC. et al; Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group. The effect of statins on cardiovascular outcomes by smoking status: a systematic review and meta-analysis of randomized controlled trials. Pharmacol Res 2017; 122: 105-117
• 6 Athyros VG, Gossios TD, Tziomalos K, Florentin M, Karagiannis A, Mikhailidis DP. Is there an additional benefit from coronary revascularization in diabetic patients with acute coronary syndromes or stable angina who are already on optimal medical treatment?. Arch Med Sci 2011; 7 (06) 1067-1075
• 7 Mukherjee D. Management of refractory angina in the contemporary era. Eur Heart J 2013; 34 (34) 2655-2657
• 8 Padala SK, Lavelle MP, Sidhu MS. et al. Antianginal therapy for stable ischemic heart disease: a contemporary review. J Cardiovasc Pharmacol Ther 2017; 22 (06) 499-510
• 9 Kones R. Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization. Vasc Health Risk Manag 2010; 6: 749-774
• 10 Vadnais DS, Wenger NK. Emerging clinical role of ranolazine in the management of angina. Ther Clin Risk Manag 2010; 6: 517-530
• 11 Levine GN, Bates ER, Bittl JA. et al. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Thorac Cardiovasc Surg 2016; 152 (05) 1243-1275
• 12 George S, Cockburn J, Clayton TC. et al; British Cardiovascular Intervention Society, National Institute for Cardiovascular Outcomes Research. Long-term follow-up of elective chronic total coronary occlusion angioplasty: analysis from the U.K. Central Cardiac Audit Database. J Am Coll Cardiol 2014; 64 (03) 235-243
• 13 Tomasello SD, Boukhris M, Giubilato S. et al. Management strategies in patients affected by chronic total occlusions: results from the Italian Registry of Chronic Total Occlusions. Eur Heart J 2015; 36 (45) 3189-3198
• 14 Christakopoulos GE, Christopoulos G, Carlino M. et al. Meta-analysis of clinical outcomes of patients who underwent percutaneous coronary interventions for chronic total occlusions. Am J Cardiol 2015; 115 (10) 1367-1375
• 15 Ong AT, Serruys PW. Complete revascularization: coronary artery bypass graft surgery versus percutaneous coronary intervention. Circulation 2006; 114 (03) 249-255
• 16 Martuscelli E, Clementi F, Gallagher MM. et al; CABRI trialists. Revascularization strategy in patients with multivessel disease and a major vessel chronically occluded; data from the CABRI trial. Eur J Cardiothorac Surg 2008; 33 (01) 4-8
• 17 Head SJ, Mack MJ, Holmes Jr DR. et al. Incidence, predictors and outcomes of incomplete revascularization after percutaneous coronary intervention and coronary artery bypass grafting: a subgroup analysis of 3-year SYNTAX data. Eur J Cardiothorac Surg 2012; 41 (03) 535-541
• 18 Farooq V, Serruys PW, Garcia-Garcia HM. et al. The negative impact of incomplete angiographic revascularization on clinical outcomes and its association with total occlusions: the SYNTAX (Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) trial. J Am Coll Cardiol 2013; 61 (03) 282-294
• 19 Henriques JP, Hoebers LP, Råmunddal T. et al; EXPLORE Trial Investigators. Percutaneous intervention for concurrent chronic total occlusions in patients with STEMI: The EXPLORE trial. J Am Coll Cardiol 2016; 68 (15) 1622-1632
• 20 Lee SW, Lee PH, Ahn JM. et al. Randomized trial evaluating percutaneous coronary intervention for the treatment of chronic total occlusion. Circulation 2019; 139 (14) 1674-1683
• 21 Werner GS, Martin-Yuste V, Hildick-Smith D. et al; EUROCTO trial investigators. A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions. Eur Heart J 2018; 39 (26) 2484-2493
• 22 Galassi AR, Sianos G, Werner GS. et al; Euro CTO Club. Retrograde recanalization of chronic total occlusions in Europe: procedural, in-hospital, and long-term outcomes from the multicenter ERCTO registry. J Am Coll Cardiol 2015; 65 (22) 2388-2400
• 23 Brilakis ES, Mashayekhi K, Tsuchikane E. et al. Guiding principles for chronic total occlusion percutaneous coronary intervention. Circulation 2019; 140 (05) 420-433
• 24 Morino Y, Abe M, Morimoto T. et al; J-CTO Registry Investigators. Predicting successful guidewire crossing through chronic total occlusion of native coronary lesions within 30 minutes: the J-CTO (Multicenter CTO Registry in Japan) score as a difficulty grading and time assessment tool. JACC Cardiovasc Interv 2011; 4 (02) 213-221
• 25 Christopoulos G, Kandzari DE, Yeh RW. et al. Development and validation of a novel scoring system for predicting technical success of chronic total occlusion percutaneous coronary interventions: the PROGRESS CTO (prospective global registry for the study of chronic total occlusion intervention) score. JACC Cardiovasc Interv 2016; 9 (01) 1-9
• 26 Danek BA, Karatasakis A, Tajti P. et al. Incidence, treatment, and outcomes of coronary perforation during chronic total occlusion percutaneous coronary intervention. Am J Cardiol 2017; 120 (08) 1285-1292
• 27 Patel VG, Brayton KM, Tamayo A. et al. Angiographic success and procedural complications in patients undergoing percutaneous coronary chronic total occlusion interventions: a weighted meta-analysis of 18,061 patients from 65 studies. JACC Cardiovasc Interv 2013; 6 (02) 128-136
• 28 Levine GN, Bates ER, Blankenship JC. et al; American College of Cardiology Foundation, American Heart Association Task Force on Practice Guidelines, Society for Cardiovascular Angiography and Interventions. 2011 ACCF/AHA/SCAI Guideline for percutaneous coronary intervention. a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol 2011; 58 (24) e44-e122
• 29 Windecker S, Kolh P, Alfonso F. et al; Authors/Task Force members. 2014 ESC/EACTS guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014; 35 (37) 2541-2619
• 30 Patel MR, Calhoon JH, Dehmer GJ. et al. ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 appropriate use criteria for coronary revascularization in patients with stable ischemic heart disease: a report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons. J Am Coll Cardiol 2017; 69 (17) 2212-2241